Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-04 · accession 0001626839-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-05 | 2025-11-04 | TRLV | Foulston Matthew J. | Dir | A - Grant | $0.00 | +11.3K | 11.3K | New | $0 |
| D | 2025-11-05 | 2025-11-04 | TRLV | Foulston Matthew J. | Dir | A - Grant | $0.00 | +18.9K | 18.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2025-11-04 | A | A | 11,329 | $0.00 | 11,329 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2031. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | A | A | 18,859 | $0.00 | 18,859 | D | $6.62 · 2025-11-04 to 2032-12-01 | 18,859 Subordinate Voting Shares | (F2) The options are fully vested. |